×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| STRIDES PHARMA SCIENCE LIMITED | 5533.45 | 149.38 | 5509.17 | 1.62 | 6,009 | 24.1 |
| Supriya Lifescience Limited | 1877.46 | 467.83 | 1856.48 | 5.82 | 5150 | 29.4 |
| UNICHEM LABORATORIES LTD. | 5,467.10 | 578.50 | 5,330.90 | 8.19 | 4850 | 57.3 |
STRIDES PHARMA SCIENCE LIMITED, with Security Code 532531, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 386.5 | 563.5 | 475.3 | 540.2 | 520.0 | 617.6 | 554.7 | 554.7 | 609.9 | 550.9 |
| Expenses | 340.9 | 444.1 | 419.8 | 497.0 | 454.4 | 526.8 | 493.7 | 493.7 | 546.9 | 476.8 |
| Operating Profit | 45.6 | 119.4 | 55.6 | 43.3 | 65.7 | 90.8 | 61.0 | 61.0 | 63.0 | 74.1 |
| OPM % | 11.8% | 21.19% | 11.69% | 8.01% | 12.63% | 14.7% | 11% | 11% | 10.33% | 13.45% |
| Other Income | 29.8 | 11.4 | 11.6 | 22.3 | 3.4 | 29.6 | 11.8 | 11.8 | 23.5 | 2.4 |
| Interest | 35.1 | 42.9 | 36.6 | 40.1 | 44.5 | 46.8 | 46.9 | 46.9 | 50.2 | 34.2 |
| Depreciation | 22.3 | 22.7 | 21.5 | 21.3 | 21.1 | 20.8 | 20.3 | 20.3 | 22.0 | 20.9 |
| Profit before tax | 18.0 | 80.2 | 9.1 | 4.2 | 8.8 | 52.9 | 5.7 | 5.7 | 14.4 | 21.4 |
| Tax % | 30.3% | 4.3% | 12.3% | 69.4% | 27.8% | 1.7% | 30.8% | 30.8% | 6.1% | 30.1% |
| Net Profit | 12.5 | 62.4 | 8.0 | 1.3 | 2.5 | 53.7 | 3.9 | 3.9 | 15.3 | 14.9 |
| EPS in Rs | 1.39 | 6.91 | 0.89 | 0.14 | 0.28 | 5.83 | 0.43 | 0.43 | 1.66 | 1.62 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Jun 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 864.8 | 986.4 | 930.0 | 999.4 | 1,037.7 | 1,084.0 | 19.3 | 19.3 | 1,087.5 | 1,201.1 |
| Expenses | 892.0 | 871.4 | 796.3 | 888.6 | 895.8 | 902.9 | 20.6 | 20.6 | 882.3 | 978.1 |
| Operating Profit | -27.1 | 115.0 | 133.7 | 110.9 | 141.8 | 181.2 | -1.2 | -1.2 | 205.2 | 223.0 |
| OPM % | -3.1% | 11.7% | 14.4% | 11.1% | 13.7% | 16.7% | -6.5% | -6.5% | 18.9% | 18.6% |
| Other Income | 67.8 | 19.8 | 2.7 | -129.1 | -1.3 | -21.6 | 1.0 | 1.0 | 9.0 | 24.5 |
| Interest | 58.4 | 80.5 | 76.4 | 78.6 | 79.3 | 80.2 | 1.5 | 1.5 | 80.4 | 82.1 |
| Depreciation | 60.2 | 60.9 | 59.6 | 60.1 | 51.2 | 49.8 | 0.3 | 0.3 | 48.6 | 50.5 |
| Profit before tax | -119.6 | 0.6 | 6.3 | 8.0 | 20.1 | 37.7 | -2.0 | -2.0 | 88.9 | 118.7 |
| Tax % | 6.3% | 20.9% | 29.1% | -6.5% | 16.3% | 24.6% | -0% | -0% | 17.4% | 16.6% |
| Net Profit | -82.1 | -13.8 | -9.4 | -149.5 | 54.1 | 10.4 | -2.0 | -2.0 | 68.3 | 93.7 |
| EPS in Rs | -8 | -1 | 0 | -14 | 5 | 1 | -1 | -1 | 7 | 10 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 7% |
| 3 Years: | 5% |
| TTM: | 15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | -8% |
| 3 Years: | -2% |
| TTM: | 389% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 22% |
| 3 Years: | 60% |
| 1 Year: | 72% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 13% |
| 3 Years: | 7% |
| TTM: | 15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -25% |
| 5 Years: | -20% |
| 3 Years: | -23% |
| TTM: | 2306% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 22% |
| 3 Years: | 60% |
| 1 Year: | 72% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|